Benefits of a 3-week outpatient balneotherapy programme on patient-reported outcomes
BACKGROUND: Analysis of the health profile of participants aged over 65 has been initiated in balneotherapy.
AIMS: To determine the benefits of a 3-week outpatient balneotherapy program on patient-reported outcomes.
METHODS: Our sample consisted of 1471 people. The average age of the study population was 72.5 years (± 5.1) and 67% of the participants were females. Symptoms intensity was measured by visual analogue scale, and health-related quality of life (HRQL) with the EQ5D questionnaire before and after the program. Changes of perceived functional status were rated using a 3-point Likert scale.
RESULTS: The results indicated a significant increase in the fear of falling and a decrease in fatigue. EQ5D reveals a significant improvement after the program. The perceived change scores remained stable, except for anxiety/depression.
CONCLUSIONS: The study indicated significant improvements of HRQL and a decrease of perception of fatigue and anxiety in elderly people participants in a 3-week balneological programme.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
|---|---|
| Enthalten in: |
Aging clinical and experimental research - 33(2021), 5 vom: 21. Mai, Seite 1389-1392 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bernard, P L [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Balneotherapy programme |
|---|
| Anmerkungen: |
Date Completed 30.04.2021 Date Revised 30.04.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s40520-020-01634-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM311429335 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM311429335 | ||
| 003 | DE-627 | ||
| 005 | 20231225142234.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40520-020-01634-9 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1038.xml |
| 035 | |a (DE-627)NLM311429335 | ||
| 035 | |a (NLM)32564305 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bernard, P L |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Benefits of a 3-week outpatient balneotherapy programme on patient-reported outcomes |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.04.2021 | ||
| 500 | |a Date Revised 30.04.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: Analysis of the health profile of participants aged over 65 has been initiated in balneotherapy | ||
| 520 | |a AIMS: To determine the benefits of a 3-week outpatient balneotherapy program on patient-reported outcomes | ||
| 520 | |a METHODS: Our sample consisted of 1471 people. The average age of the study population was 72.5 years (± 5.1) and 67% of the participants were females. Symptoms intensity was measured by visual analogue scale, and health-related quality of life (HRQL) with the EQ5D questionnaire before and after the program. Changes of perceived functional status were rated using a 3-point Likert scale | ||
| 520 | |a RESULTS: The results indicated a significant increase in the fear of falling and a decrease in fatigue. EQ5D reveals a significant improvement after the program. The perceived change scores remained stable, except for anxiety/depression | ||
| 520 | |a CONCLUSIONS: The study indicated significant improvements of HRQL and a decrease of perception of fatigue and anxiety in elderly people participants in a 3-week balneological programme | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Balneotherapy programme | |
| 650 | 4 | |a Intervention study | |
| 650 | 4 | |a Patient-reported outcomes | |
| 650 | 4 | |a Perceived change | |
| 650 | 4 | |a Quality of life | |
| 700 | 1 | |a Ninot, G |e verfasserin |4 aut | |
| 700 | 1 | |a Raffort, N |e verfasserin |4 aut | |
| 700 | 1 | |a Aliaga, B |e verfasserin |4 aut | |
| 700 | 1 | |a Gamon, L |e verfasserin |4 aut | |
| 700 | 1 | |a Faucanie, M |e verfasserin |4 aut | |
| 700 | 1 | |a Picot, M C |e verfasserin |4 aut | |
| 700 | 1 | |a Maurelli, O |e verfasserin |4 aut | |
| 700 | 1 | |a Pla, S |e verfasserin |4 aut | |
| 700 | 1 | |a Soriteau, L |e verfasserin |4 aut | |
| 700 | 1 | |a Bousquet, J |e verfasserin |4 aut | |
| 700 | 1 | |a Blain, H |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Aging clinical and experimental research |d 2002 |g 33(2021), 5 vom: 21. Mai, Seite 1389-1392 |w (DE-627)NLM119023741 |x 1720-8319 |7 nnns |
| 773 | 1 | 8 | |g volume:33 |g year:2021 |g number:5 |g day:21 |g month:05 |g pages:1389-1392 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s40520-020-01634-9 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 33 |j 2021 |e 5 |b 21 |c 05 |h 1389-1392 | ||